“Inflammasomes As a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature”. 2023. Principles and Practice of Clinical Research 9 (2). https://doi.org/10.21801/ppcrj.2023.92.7.